Updated Use Instructions for Maquet Servo Ventilator Systems
Risk in Neonatal Tidal Volume Delivery
Maquet Servo Ventilator Systems
Source: FDA
Urgent Class I Medical Device Correction
Maquet Critical Care AB, a subsidiary of Getinge, has issued an urgent correction notice regarding its Servo Ventilator Systems (Servo-u, Servo-n, and Servo-u MR). This correction does not involve product removal, but the FDA has classified it as a Class I recall, the most serious type, due to the potential risk of injury or death if devices are used incorrectly.
Device Overview
These ventilators are used in professional healthcare settings for neonatal, pediatric, and adult patients, including in MR environments (Servo-u MR only). The devices assist or control breathing by delivering oxygen-rich air at controlled volumes.
Issue Summary
Maquet has updated its user instructions after discovering that incorrect configuration of the “Extended leakage test” could cause inaccurate compliance measurements, especially dangerous for neonatal patients. This could result in improper tidal volume delivery:
- In PRVC mode, up to 50% less tidal volume may be delivered than displayed.
- In Pressure Control mode, displayed tidal volume may appear higher than what is delivered.
Health Risks
Improper tidal volume delivery may cause hypoventilation, hypoxia, or hypercapnia, particularly in extremely premature neonates. One injury has been reported, with no deaths to date.
Recommended Actions
Issued on May 30, 2025, the correction letter advises:
- Set the “Extended leakage test” to OFF unless using a compatible humidifier (see User Manual, Chapter 8.2.4).
- Follow revised safety check instructions in Appendix 1, Chapter 9.5.1 of the user’s manual.
- Notify all affected personnel and verify all ventilators are properly configured.
Contact Info
For technical assistance, U.S. customers can reach Maquet Technical Services at 1-888-943-8872 (Option 4), weekdays 8:00 a.m. to 6:00 p.m. ET.
Read the original medical device alert here.
Class I Recall for Intra-Aortic Blood Pumps
Datascope/Getinge IABPs May Malfunction Due to Cable Failure The US Food and Drug Administration (FDA) announced yesterday that Datascope/Getinge is recalling certain CARDIOSAVE Hybrid and Rescue Intra-Aortic Balloon Pumps (IABP) due to a risk of device malfunction....
Urgent Action Required – Baxter LIFE2000 System
Software issue can cause potential harm or death On March 10, the US Food and Drug Administration (FDA) announced that Baxter International Inc. has issued an urgent medical device correction for its LIFE2000 Ventilation System. An issue with the device’ software may...